Physician profile
Anna S Bouchard
NPI 1477062594
$2,379.64
in general payments reported to CMS, 2019-2025
6 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $120 · 2023: $1,637 · 2024: $261 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,109 · Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,109.34 |
| Food and Beverage | $950.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,319.06 | 2021-2023 | Pipeline |
| Depuy Synthes Sales INC. | $428.04 | 2021-2025 | Cerepak Uniform, Emboguard, Embotrap |
| Rapid Medical LTD | $245.39 | 2022-2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Medical Device Business Services, INC. | $206.86 | 2023-2024 | Trufill |
| Amgen INC. | $165.94 | 2024-2025 | Repatha, Repatha |
| Aroa Biosurgery Incorporated | $14.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bouchard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.